Answers are grounded in this paper and cite their sources.
Starting from two weak mGlu 2 receptor positive allosteric modulator (PAM) HTS hits ( 4 and 5 ), a molecular hybridization strategy resulted in the identification of a novel spiro-oxindole piperidine series with improved activity and metabolic stability. Scaffold hopping around the spiro-oxindole core identified the 3-(azetidin-3-yl)-1 H -benzimidazol-2-one as bioisoster. Medicinal chemistry optimization of these two novel chemotypes resulted in the identification of potent, selective, orally bioavailable, and brain penetrant mGluR 2 PAMs.
No takes yet. Share an insight, caveat, or question.
Lucas et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: